Emerging treatments
Intrapericardial fibrinolysis
This treatment is being investigated as an adjunct therapy for patients with infective pericarditis (i.e., tuberculous and purulent) where there is a high risk of constrictive pericarditis. Case reports and small trials have shown promising results; however, these results need to be replicated on a larger basis before this therapy is recommended.
Use of this content is subject to our disclaimer